ATPC: Agape ATP Corp Company Short-Term Debt

Symbol and logo of brand Agape ATP Corp. (ATPC)

Agape ATP Corporation (ATPC) relies on the moderate cyclicality of healthcare spending and high margins driven by a loyal community in Southeast Asia. The short-term borrowed capital trend captures the current debt load, where 0.00 serves as the current metric level. Business resilience is underpinned by the Asian wellness ecosystem and digital customer acquisition for longevity programs.

ATPC (agapeatpgroup.com) Company Short-Term Debts history from 02/21/2024 to 10/31/2026

ATPC (Agape ATP Corp): analytical breakdowns and indicator data

- current quotes and average value forecast:
Price Chart Agape ATP Corp.|ATPC - Fair Value Consensus
- market capitalization information:
Market Value Agape ATP Corporation|ATPC - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Agape ATP|ATPC - Book Capitalization|Market Cap to Net Assets Ratio agapeatpgroup.com|ATPC - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Agape ATP Corporation|ATPC - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Agape ATP Corp.|ATPC - Company Cumulative Debt|Debt to Book Value Agape ATP Corporation|ATPC - Amount of Long-Term Liabilities|Company Short-Term Debts Agape ATP|Quick Ratio agapeatpgroup.com
- net income and valuation multiples indicators:
ATPC - Company Net Income
Basic company analysis:agapeatpgroup.com - ATPC
Mass-produced product of Agape ATP Corp

Investors are assessing the resilience of Agape ATP Corporation (ATPC) through liquidity, where the total amount of loans and promissory notes maturing within one year determines the risk of a cash shortfall. By analyzing aggregate short-term liabilities, one can determine whether profits from the sale of nutraceuticals and preventive medicine in Asia are sufficient to service debt without compromising the expansion of the center network.

Who Agape ATP Corporation competes with

ASND - Company Short-Term Debt|Company Short-Term Loans and Borrowings MDGL (Madrigal Pharmaceuticals Inc)|Corcept (CORT) - Company Short-Term Debt|Company Current Liabilities Rhythm Corp|AKRO (Akero Therapeutics) - Company Short-Term Debts|Company Short-Term Debts metsera.com|Company Current Liabilities MLTX (MoonLake)|CRNX (Crinetics Pharmaceuticals, Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt NewAmsterdam Pharma N.V. NAMS|SLNO - Company Current Liabilities|Amicus Therapeutics - Company Short-Term Debts|Short-Term Debt 89bio.com|AGIO (Agios Pharmaceuticals, Inc.) - Company Current Liabilities|GPCR: Amount of Current Liabilities|MDXG (MiMedx Group) - Company Short-Term Debts|Company Short-Term Debts Rezolute Bio|Company Short-Term Debts LXRX|Company Short-Term Debt MBX (mbxbio.com)|Company Short-Term Debt Altimmune ALT|Aardvark Therapeutics Inc. (AARD) - Short-Term Debt|SGMT - Company Short-Term Debt|BIOA: Company Short-Term Debt|BMEA: Company Short-Term Debts|QNCX - Short-Term Debt Volume|Company Short-Term Debt Fractyl Health|vTv Therapeutics Inc (VTVT) - Short-Term Debt Volume|Company Short-Term Debt Pluri Inc. (PLUR)|Company Current Liabilities synlogictx.com SYBX|Company Short-Term Debts LPCN (Lipocine Inc.)|Company Short-Term Debts Matinas BioPharma Holdings, Inc. MTNB|Spruce Biosciences - Company Short-Term Debts|Short-Term Indebtedness Galecto Inc (GLTO)|CTCX: Company Short-Term Debts|Lumos Therapeutics (LUMO) - Company Short-Term Debts|Company Short-Term Debt Organovo Holdings, Inc.|radiuspharm.com - Current Liabilities